Considering that the NF-κB and NLRP3 inflammasome pathways are related to the development of many inflammatory diseases, neoastilbin may have potential clinical application value in gout, autoinflammatory syndrome or other NLRP3-driven diseases [41,42,43,44]. Here, NFKB1 is linked to autoinflammatory syndrome.